Skip to content

FDA Conditionally Approves First Drug to Control Acute Onset Pancreatitis in Dogs

For immediate publication: November 15, 2022 Today, the US Food and Drug Administration conditionally approved Panoquell-CA1 (fuzapladib sodium injection) for the treatment of clinical signs associated with acute onset pancreatitis in dogs. Panoquell-CA1 is an injectable drug intended to be used while the dog is… Read More »FDA Conditionally Approves First Drug to Control Acute Onset Pancreatitis in Dogs